Zestmab 500 mg Injection
  1. Home
  2. Pharma Products
  3. RPG Life Sciences Ltd
  4. Zestmab 500 mg Injection

Zestmab 500 mg Injection

Zestmab 500 mg Injection contains rituximab 500 mg, a monoclonal antibody used for certain blood cancers and autoimmune disorders. It targets CD20-positive B cells and helps reduce abnormal or overactive B-cell activity. The product is administered by intravenous infusion under the supervision of a healthcare professional.

BUY NOW

Category

Rituximab binds to the CD20 antigen on B cells and promotes their elimination through immune-mediated mechanisms. Zestmab is used in conditions including non-Hodgkin lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, and certain vasculitis disorders. The 500 mg presentation contains rituximab 500 mg in a 50 mL vial, with a concentration of 10 mg/mL. Zestmab 500 mg Injection is marketed by RPG Life Sciences Ltd and should be stored refrigerated at 2°C–8°C without freezing.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Concentration 10 mg/mL
Pack Size 50 mL vial
Dosage Form Solution for infusion
Manufacturer/Marketer RPG Life Sciences Ltd

Product Also Known As

Zestmab 500 mg Injection, Zestmab 500 mg/50 mL, Zestmab 500 Injection, Zestmab Rituximab Injection, Rituximab 500 mg Injection, Rituximab 500 mg/50 mL